Headache response after CT‐guided fibrin glue occlusion of CSF‐venous fistulas.

Objective: To assess headache response and patient perception of improvement after computed tomography (CT)‐guided fibrin glue occlusion of cerebrospinal fluid‐venous fistulas (CVFs) in a large sample size and with a long clinical follow‐up. Background: CVFs are an increasingly identified type of spinal leak in patients with spontaneous intracranial hypotension (SIH), and CT‐guided fibrin glue occlusion has been introduced as a treatment option in a prior small series. Methods: Retrospective case series review of medical records from a single institution was performed for all patients with CVFs that were treated with CT‐guided fibrin glue occlusion between August 2018 and April 2022 in an outpatient or inpatient setting. Pre‐ and posttreatment Headache Impact Tests (HIT‐6) were administered to patients, and a change in scores was evaluated. In some patients, pretreatment HIT‐6 tests were not obtained prior to the fibrin glue procedure, and the patient was asked to fill out the pretreatment test based on personal recall of their symptoms prior to treatment. Patients completed a Patient Global Impression of Change (PGIC) scale after treatment. Pre‐ and posttreatment brain imaging was compared using Bern SIH scores. Results: Thirty‐five patients (19 females, 16 males; mean age 60 years) with CVFs treated with CT‐guided fibrin glue occlusion met the inclusion criteria. Mean pretreatment and posttreatment HIT‐6 scores were 64.7 ± 10.2 and 43.4 ± 9.9 (p < 0.001), respectively. The posttreatment HIT‐6 questionnaires were completed on average 10.3 months after treatment, and 20 patients filled out the pretreatment HIT‐6 form after their treatment. The mean PGIC score was 6.1 ± 1.3. Mean pretreatment and posttreatment Bern SIH scores were 5.9 ± 2.5 and 1.5 ± 1.5 (p < 0.001), respectively. Conclusions: We report a large series of patients who underwent CT‐guided fibrin glue occlusion of CVFs. We showed that headache scores decreased after treatment, and the majority of patients had high PGIC scores. Posttreatment brain MRIs also showed improved Bern SIH scores. [ABSTRACT FROM AUTHOR]